𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal role of temozolomide in the treatment of malignant gliomas

✍ Scribed by Roger Stupp; Martin J. van den Bent; Monika E. Hegi

Book ID
107543438
Publisher
Springer
Year
2005
Tongue
English
Weight
400 KB
Volume
5
Category
Article
ISSN
1528-4042

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Temozolomide in the treatment of recurre
Temozolomide in the treatment of recurrent malignant glioma
✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

The treatment of malignant gliomas
The treatment of malignant gliomas
✍ Mark R. Gilbert; Monica Loghin πŸ“‚ Article πŸ“… 2005 πŸ› Springer 🌐 English βš– 568 KB
The potential role of lonidamine (LND) i
The potential role of lonidamine (LND) in the treatment of malignant glioma
✍ Carmine M. Carapella; Marco G. Paggi; Fabio Cattani; Giovanni B. Ciottoli; Arist πŸ“‚ Article πŸ“… 1989 πŸ› Springer US 🌐 English βš– 397 KB

Up-to-date unsatisfactory results obtained in multimodality treatments of malignant glioma have prompted the research of new therapeutic modalities with 'unconventional' modes of action. Lonidamine (LND) is a drug which reduces aerobic glycolytic activity in both human and experimental tumors. This